White J G
Department of Laboratory Medicine/Pathology, University of Minnesota Medical School, Minneapolis 55455.
Adv Hum Genet. 1990;19:133-234. doi: 10.1007/978-1-4757-9065-8_3.
As diverse as the group of inherited structural defects and giant platelet disorders presented in this chapter may seem, there is a common thread that ties them together. All appear to represent some form of membrane aberration. Sometimes only a small inclusion identifies the membrane defect, sometimes a massive increase in size. In others, whole populations of organelles are missing or surface membranes lack specific glycoproteins essential for their function. All of them are born in the deep recesses of a hidden cell, the bone marrow megakaryocyte. Getting the megakaryocyte out into the light of day, or at least into a culture medium, should certainly lead to the solution of many, if not all, of the disorders of platelet membranes and membrane disorders. We have not been completely successful in our efforts to study the megakaryocyte in vitro. As a result, we do not yet understand the normal megakaryocyte, much less normal platelet. The megakaryocyte presents one of the greatest of challenges to our understanding of membrane biology. As our knowledge of how its cytoplasm fills with interiorly and exteriorly derived membranes, and the mechanisms underlying their organization into platelet surfaces, channels of the OCS and DTS, membrane complexes, and five kinds of organelles become clear, our ability to define the basic nature and inheritance of defects will improve rapidly. Within the next decade most aspects of platelet molecular genetics and cell biology will be solved.
尽管本章中介绍的遗传性结构缺陷和巨大血小板疾病群体看起来多种多样,但有一条共同的线索将它们联系在一起。所有这些似乎都代表了某种形式的膜异常。有时只有一个小包涵体能识别膜缺陷,有时则是大小大幅增加。在其他情况下,整个细胞器群体缺失,或者表面膜缺乏其功能所必需的特定糖蛋白。所有这些都源自一个隐藏细胞——骨髓巨核细胞的深处。将巨核细胞带出黑暗,或者至少带入培养基中,肯定会导致解决许多(如果不是全部)血小板膜紊乱和膜相关疾病。我们在体外研究巨核细胞的努力尚未完全成功。因此,我们还不了解正常的巨核细胞,更不用说正常的血小板了。巨核细胞对我们理解膜生物学构成了最大的挑战之一。随着我们对其细胞质如何充满内外来源的膜,以及这些膜组织成血小板表面、OCS和DTS通道、膜复合物以及五种细胞器的潜在机制的了解变得清晰,我们定义缺陷的基本性质和遗传方式的能力将迅速提高。在未来十年内,血小板分子遗传学和细胞生物学的大多数方面将得到解决。